Skip to main content
. 2021 Jan 6;11(2):125–131. doi: 10.1016/j.jobcr.2021.01.004

Table 4.

Correlation of histopathological grading and clinical staging with post-treatment general and oral health related quality of life.

Parameters N OHIP-14
SF-12
PCS
MCS
1-month post-treatment
6-months post-treatment
1-month post-treatment
6-months post-treatment
1-month post-treatment
6-months post-treatment
mean SD mean SD mean SD mean SD mean SD mean SD
Histopatho-logical grading WDSCC (A) 37 11.27 3.54 3.64 4.47 68.24 24.31 79.22 22.87 71.35 11.22 79.59 11.07
MDSCC (B) 84 21.38 5.49 14.98 7.11 58.25 25.28 72.39 26.18 54.76 14.53 70.77 14.15
PDSCC (C) 14 19.78 3.78 12.50 3.77 74.10 4.14 92.41 6.09 61.78 4.64 80.00 4.38
p-value B ​> ​A (p<0.001),
C>A (p<0.001),
B>C (p ​= ​0.496)
B ​> ​A (p<0.001),
C>A (p<0.001),
B>C (p ​= ​0.351)
B ​> ​A (p ​= ​0.088),
C ​> ​A (p ​= ​0.712),
B ​< ​C (p ​= ​0.058)
B ​< ​A (p ​= ​0.323),
C ​> ​A (p ​= ​0.191),
B ​< ​C (p ​= ​0.013)
B ​< ​A (p ​< ​0.001),
C ​< ​A (p ​= ​0.054),
B ​< ​C (p ​= ​0.152)
B ​< ​A (p ​= ​0.002),
C ​> ​A (p ​= ​0.994),
B ​< ​C (p ​= ​0.035)
Clinical TNM Staging Stage I (A) 16 10.00 2.25 2.18 2.31 73.82 20.31 82.03 20.26 75.93 4.55 82.50 5.77
Stage II (B) 17 11.00 2.17 3.11 2.44 65.44 27.43 77.20 25.85 69.70 14.83 79.41 14.56
Stage III (C) 24 15.75 6.25 9.41 7.84 66.92 20.06 81.51 17.62 64.16 13.40 77.29 8.59
Stage IV (D) 78 22.62 3.81 16.08 5.70 58.41 24.89 73.39 26.86 53.39 12.49 70.32 14.08
p-value A ​< ​B (p ​= ​0.895),
A ​< ​C (p ​< ​0.001),
A ​< ​D (p ​< ​0.001),
B ​< ​C (p ​= ​0.002),
B ​< ​D (p ​< ​0.001),
C ​< ​D (p ​< ​0.001)
A ​< ​B (p ​= ​0.964),
A ​< ​C (p ​= ​0.001),
A ​< ​D (p ​< ​0.001),
B ​< ​C (p ​= ​0.003),
B ​< ​D (p ​< ​0.001),
C ​< ​D (p<0.001).
A>B (p ​= ​0.747),
A ​> ​C (p ​= ​0.809),
A ​> ​D (p ​= ​0.093),
B ​< ​C (p ​= ​0.997),
B ​> ​D (p ​= ​0.693),
C ​> ​D (p ​= ​0.427
A ​> ​B (p ​= ​0.943),
A ​> ​C (p ​= ​1.000),
A ​> ​D (p ​= ​0.579),
B ​< ​C (p ​= ​0.946),
B ​> ​D (p ​= ​0.939),
C ​> ​D (p ​= ​0.495)
A ​> ​B (p ​= ​0.472),
A ​> ​C (p ​= ​0.019),
A ​> ​D (p<0.001),
B>C (p ​= ​0.493),
B ​> ​D (p<0.001),
C>D (p ​= ​0.002)
A ​> ​B (p ​= ​0.896),
A ​> ​C (p ​= ​0.578),
A ​> ​D (p ​= ​0.003),
B ​> ​C (p ​= ​0.952),
B ​> ​D (p ​= ​0.040),
C ​> ​D (p ​= ​0.089)

WDSCC: Well differentiated squamous cell carcinoma; MDSCC: Moderately differentiated squamous cell carcinoma; PDSCC: Poorly differentiated squamous cell carcinoma; SD: standard deviation.